Consensus guideline for the management of patients with appendiceal tumors, part 1: Appendiceal tumors without peritoneal involvement.
Consensus guideline for the management of patients with appendiceal tumors, part 1: Appendiceal tumors without peritoneal involvement. Cancer. 2025 Jul 01; 131(13):e35867.
PMID: 40558045
Consensus guideline for the management of colorectal cancer with peritoneal metastases.
Consensus guideline for the management of colorectal cancer with peritoneal metastases. Cancer. 2025 Jul 01; 131(13):e35869.
PMID: 40558054
Consensus guideline for the management of patients with appendiceal tumors, part 2: Appendiceal tumors with peritoneal involvement.
Consensus guideline for the management of patients with appendiceal tumors, part 2: Appendiceal tumors with peritoneal involvement. Cancer. 2025 Jul 01; 131(13):e35874.
PMID: 40558065
Utilizing Patient Input in Rectal Cancer Trial Design.
Utilizing Patient Input in Rectal Cancer Trial Design. J Natl Cancer Inst. 2025 Jul 01; 117(7):1421-1428.
PMID: 40108482
Consensus Guideline for the Management of Patients with Appendiceal Tumors, Part 2: Appendiceal Tumors with Peritoneal Involvement.
Consensus Guideline for the Management of Patients with Appendiceal Tumors, Part 2: Appendiceal Tumors with Peritoneal Involvement. Ann Surg Oncol. 2025 Jun 25.
PMID: 40560501
Consensus Guideline for the Management of Patients with Appendiceal Tumors, Part 1: Appendiceal Tumors Without Peritoneal Involvement.
Consensus Guideline for the Management of Patients with Appendiceal Tumors, Part 1: Appendiceal Tumors Without Peritoneal Involvement. Ann Surg Oncol. 2025 Jun 25.
PMID: 40560498
Consensus Guideline for the Management of Colorectal Cancer with Peritoneal Metastases.
Consensus Guideline for the Management of Colorectal Cancer with Peritoneal Metastases. Ann Surg Oncol. 2025 Jun 25.
PMID: 40560497
Systemic chemotherapy in patients with unresectable pseudomyxoma peritonei from low-grade appendiceal mucinous neoplasms: a case series.
Systemic chemotherapy in patients with unresectable pseudomyxoma peritonei from low-grade appendiceal mucinous neoplasms: a case series. J Gastrointest Oncol. 2025 Apr 30; 16(2):757-765.
PMID: 40386613
Defining a 'cells to society' research framework for appendiceal tumours.
Defining a 'cells to society' research framework for appendiceal tumours. Nat Rev Cancer. 2025 Apr; 25(4):293-315.
PMID: 39979656
Diagnostic Challenges due to a Germline Missense MSH2 Variant in a Patient With Immunotherapy-Responsive Locally Advanced Rectal Adenocarcinoma.
Diagnostic Challenges due to a Germline Missense MSH2 Variant in a Patient With Immunotherapy-Responsive Locally Advanced Rectal Adenocarcinoma. Cancer Rep (Hoboken). 2024 Dec; 7(12):e70037.
PMID: 39696980